OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
6.43
+0.44 (7.35%)
Mar 23, 2026, 4:00 PM EDT - Market closed
OptimizeRx Revenue
In the year 2025, OptimizeRx had annual revenue of $109.43M with 18.78% growth. OptimizeRx had revenue of $32.24M in the quarter ending December 31, 2025, a decrease of -0.24%.
Revenue (ttm)
$109.43M
Revenue Growth
+18.78%
P/S Ratio
1.10
Revenue / Employee
$822,774
Employees
133
Market Cap
120.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.43M | 17.30M | 18.78% |
| Dec 31, 2024 | 92.13M | 20.61M | 28.81% |
| Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
| Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
| Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
| Dec 31, 2020 | 43.31M | 18.72M | 76.08% |
| Dec 31, 2019 | 24.60M | 3.39M | 15.99% |
| Dec 31, 2018 | 21.21M | 9.08M | 74.86% |
| Dec 31, 2017 | 12.13M | -3.38M | -21.77% |
| Dec 31, 2016 | 15.50M | 8.28M | 114.70% |
| Dec 31, 2015 | 7.22M | 717.72K | 11.04% |
| Dec 31, 2014 | 6.50M | 1.82M | 38.96% |
| Dec 31, 2013 | 4.68M | 2.69M | 135.27% |
| Dec 31, 2012 | 1.99M | -233.95K | -10.52% |
| Dec 31, 2011 | 2.22M | 2.08M | 1,464.09% |
| Dec 31, 2010 | 142.13K | 115.41K | 431.86% |
| Dec 31, 2009 | 26.72K | -56.96K | -68.07% |
| Dec 31, 2008 | 83.69K | -16.63K | -16.58% |
| Dec 31, 2007 | 100.32K | - | - |
| Dec 31, 2006 | 0 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Claritev | 965.41M |
| TruBridge | 347.27M |
| Health Catalyst | 311.14M |
| American Well | 249.33M |
| Definitive Healthcare | 241.52M |
| LifeMD | 194.06M |
| Spok Holdings | 139.71M |
| CareCloud | 120.50M |
OPRX News
- 17 days ago - OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Benzinga
- 18 days ago - OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 18 days ago - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET - GlobeNewsWire
- 2 months ago - OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - GlobeNewsWire
- 3 months ago - OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story - Seeking Alpha
- 3 months ago - OptimizeRx Continues Expansion of the Company's Point-Of-Care Network - GlobeNewsWire